Changing steps: Rewriting the rules of the biologics patent dance
_____
With several blockbuster biologics set to lose exclusivity in the US by 2030, biosimilars are preparing to make their move. But, in order to make it to market, they must first master the complex choreography of “the patent dance”
April 2024: Market Access
Read article